CN Patent

CN114712321B — 磷酸二氨基吡啶缓释片及其制备方法

Assigned to Hebei Yipin Biomedical Co ltd · Expires 2024-05-24 · 2y expired

What this patent protects

本发明涉及医药制剂技术领域，公开了一种磷酸二氨基吡啶缓释片。本发明所述磷酸二氨基吡啶缓释片所用辅料种类少，处方工艺简单，具有缓释效果好、释药重现性好、产品稳定性高等优点。

USPTO Abstract

本发明涉及医药制剂技术领域，公开了一种磷酸二氨基吡啶缓释片。本发明所述磷酸二氨基吡啶缓释片所用辅料种类少，处方工艺简单，具有缓释效果好、释药重现性好、产品稳定性高等优点。

Drugs covered by this patent

amifampridine-phosphate (AMIFAMPRIDINE PHOSPHATE)

Patent Metadata

Patent number: CN114712321B
Jurisdiction: CN
Classification: —
Expires: 2024-05-24
Drug substance claim: No
Drug product claim: No
Assignee: Hebei Yipin Biomedical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.